Fundraising Fox
Blue Cell Therapeutics
Founded 2019 · 16 employees on LinkedIn · 1 known investors
Find your way into Blue Cell Therapeutics
Sign up to see every warm intro you have to Blue Cell Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Blue Cell Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Blue Cell Therapeutics develops an off-the-shelf allogeneic stem cell therapy platform (Blue Cells) that promotes angiogenesis and nerve repair, with a lead candidate (BlueC-231) aimed at treating severe erectile dysfunction in men after radical prostatectomy. The company operates in the biotech and cell therapy space, targeting patients unresponsive to existing drug treatments.
Founders & leadership
Blue Cell Therapeutics was founded in 2019 by Søren P Sheikh.
SP
Søren P SheikhFounderSøren P Sheikh holds a doctorate focused on gut and neuropeptides and their 7TM receptors, with research spanning stem cell differentiation, signal transduction in the cardiovascular system, and clinical implementation of stem cell therapies. He founded and directs the Danish Centre for Regenerative Medicine at Odense University Hospital, heads its Department of Clinical Biochemistry & Pharmacology and the regional GCP unit, and is the founder of Blue Cell Therapeutics, a biotech company developing allogeneic stem cell therapies for angiogenesis and nerve repair.
Investors · 1
Frequently asked questions
- What does Blue Cell Therapeutics do?
- Blue Cell Therapeutics develops an off-the-shelf allogeneic stem cell therapy platform (Blue Cells) that promotes angiogenesis and nerve repair, with a lead candidate (BlueC-231) aimed at treating severe erectile dysfunction in men after radical prostatectomy. The company operates in the biotech and cell therapy space, targeting patients unresponsive to existing drug treatments.
- Who founded Blue Cell Therapeutics?
- Blue Cell Therapeutics was founded by Søren P Sheikh in 2019.
- Who are Blue Cell Therapeutics's investors?
- Blue Cell Therapeutics's investors include Seier Capital.